TRACON Pharmaceuticals Inc (TCON)
1.88
+0.06
(+3.30%)
USD |
NASDAQ |
Apr 23, 13:38
TRACON Pharmaceuticals Enterprise Value: -4.423M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | -4.423M |
| April 19, 2024 | -4.105M |
| April 18, 2024 | -3.763M |
| April 17, 2024 | -3.354M |
| April 16, 2024 | -4.673M |
| April 15, 2024 | -4.469M |
| April 12, 2024 | -3.194M |
| April 11, 2024 | -2.671M |
| April 10, 2024 | -1.716M |
| April 09, 2024 | -0.9148M |
| April 08, 2024 | 0.1728M |
| April 05, 2024 | 3.053M |
| April 04, 2024 | 3.372M |
| April 03, 2024 | 1.424M |
| April 02, 2024 | 10.35M |
| April 01, 2024 | 10.15M |
| March 28, 2024 | 10.99M |
| March 27, 2024 | 10.10M |
| March 26, 2024 | 11.00M |
| March 25, 2024 | 12.37M |
| March 22, 2024 | 12.21M |
| March 21, 2024 | 11.32M |
| March 20, 2024 | 8.364M |
| March 19, 2024 | 9.160M |
| March 18, 2024 | 7.868M |
| Date | Value |
|---|---|
| March 15, 2024 | 8.50M |
| March 14, 2024 | 11.35M |
| March 13, 2024 | 20.15M |
| March 12, 2024 | 9.183M |
| March 11, 2024 | 4.632M |
| March 08, 2024 | 2.676M |
| March 07, 2024 | 2.016M |
| March 06, 2024 | 0.4003M |
| March 05, 2024 | -0.032M |
| March 04, 2024 | 0.0135M |
| March 01, 2024 | -0.0092M |
| February 29, 2024 | -0.4023M |
| February 28, 2024 | -0.709M |
| February 27, 2024 | -0.5421M |
| February 26, 2024 | -0.3122M |
| February 23, 2024 | -1.074M |
| February 22, 2024 | -0.4565M |
| February 21, 2024 | -0.3978M |
| February 20, 2024 | -0.1724M |
| February 16, 2024 | -0.1408M |
| February 15, 2024 | 0.0125M |
| February 14, 2024 | -0.1527M |
| February 13, 2024 | 0.0687M |
| February 12, 2024 | 0.2679M |
| February 09, 2024 | -0.2457M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-7.595M
Minimum
Jun 06 2019
149.07M
Maximum
Dec 31 2020
26.21M
Average
20.21M
Median
Dec 14 2021
Enterprise Value Benchmarks
| BioSig Technologies Inc | 17.25M |
| Revolution Medicines Inc | 4.142B |
| Perspective Therapeutics Inc | 890.47M |
| Electromed Inc | 124.84M |
| Xtant Medical Holdings Inc | 125.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.439M |
| Revenue (Quarterly) | 3.045M |
| Total Expenses (Quarterly) | 0.263M |
| EPS Diluted (Quarterly) | 0.40 |
| Profit Margin (Quarterly) | 14.42% |
| Earnings Yield | -266.0% |
| Normalized Earnings Yield | -311.56 |